Recent Advances in Phenylketonuria: A Review

Andrea M Zuñiga Vinueza1

  • 1School of Medicine, Catholic University of Santiago of Guayaquil, Guayaquil, ECU.

Cureus
|July 17, 2023
PubMed

Insights

Phenylketonuria (PKU) is an inborn error of metabolism affecting phenylalanine levels. Early diagnosis and improved treatments are crucial for optimizing outcomes in PKU patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Inborn errors of metabolism represent a significant health concern.
  • Phenylketonuria (PKU) is a well-characterized genetic disorder resulting from phenylalanine hydroxylase (PAH) deficiency.
  • Mutations in the PAH gene disrupt phenylalanine metabolism, leading to health complications.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of phenylketonuria (PKU).
  • To analyze the impact of PAH gene mutations on phenylalanine metabolism.
  • To highlight the importance of early detection and management strategies for PKU patients.

Main Methods:

  • A comprehensive literature review of 40 articles published between 2019 and 2023.
  • Analysis of studies focusing on diagnostic innovations, treatment strategies, and long-term PKU management.
  • Synthesis of current knowledge on PAH gene mutations and their metabolic consequences.

Main Results:

  • Significant innovations in PKU screening and diagnostic methods have emerged.
  • Advancements in treatment and management strategies offer improved patient outcomes.
  • Understanding of PAH gene mutations and their role in phenylalanine metabolism has deepened.

Conclusions:

  • Early diagnosis of PKU is critical for effective management.
  • Ongoing research into screening methods and therapeutic approaches is essential for optimizing patient care.
  • This review provides valuable insights for healthcare professionals managing children with PKU.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
203
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.3K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
38
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
446